Recent events
Recent events tied to this brand in public sources.
Back to profile7 entries
2026
Wockhardt reports Q1 FY27 profit
Wockhardt reported consolidated net profit of Rs 107 crore for Q1 FY27, compared with a loss of Rs 108 crore a year earlier.
2026
Wockhardt launches Antibiotic Academy
Wockhardt announced the launch of the Wockhardt Antibiotic Academy, an open scientific learning platform for doctors focused on evidence-based dialogue on antimicrobial resistance and appropriate antibiotic use.
2021
Wockhardt partners with RDIF to produce and supply Sputnik vaccines
Wockhardt partnered with the Russian Direct Investment Fund to produce and supply Sputnik V and Sputnik Light COVID-19 vaccines. The agreement was reached under the aegis of Enso Healthcare, RDIF’s coordination partner for sourcing Sputnik V vaccines in India.
2021
Wockhardt and RDIF vaccine production and supply partnership
Wockhardt and the Russian Direct Investment Fund (RDIF) partnered to produce and supply Sputnik V and Sputnik Light COVID-19 vaccines. The agreement was reached under the aegis of Enso Healthcare, RDIF's coordination partner for sourcing Sputnik V vaccines in India.
2020
Wockhardt appoints Akhilesh Gupta as additional director
Wockhardt appointed Akhilesh Gupta as an additional director, serving as a non-executive, independent director, effective August 29, 2020.
2020
Wockhardt announces UK COVID-19 vaccine manufacturing agreement
Wockhardt announced an agreement with the UK Government to fill and finish COVID-19 vaccines. Manufacturing is to take place at CP Pharmaceuticals, a Wockhardt subsidiary in Wrexham, and the agreement reserves manufacturing capacity for multiple vaccine candidates.
2020
Dr. Reddy’s completes acquisition of selected Wockhardt business divisions
Dr. Reddy’s Laboratories completed its acquisition of selected divisions of Wockhardt’s branded generics business in India and several other territories. The transferred business included 62 brands, related sales and marketing teams, and a manufacturing plant.